Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2022 07:30 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Announces Seven Oral Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2022

REDWOOD CITY, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
February 28, 2022 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress

RAS(ON) Inhibitor Pipeline Continues to Advance and Expand, Now Addressing Majority of RAS-Addicted Cancers; Two New Drug Candidates Recently Nominated Recently Announced First Patient Dosed in...
February 03, 2022 08:00 ET | Source: Brain Scientific Inc.

Piezo Motion Announces a Partnership to Expand Its Disruptive Precision Motor Technology

LAKEWOOD RANCH, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Applied Mechatronics today announce a partnership. Piezo Motion...
January 11, 2022 06:25 ET | Source: Mission Matters Business Podcast

Zev Asch Speaks About Disruptive Thinking for Small Business Owners

Beverly Hills , Jan. 11, 2022 (GLOBE NEWSWIRE) -- Zev Asch's mission and purpose are one and the same: to change the lives of business owners by helping them grow their companies and achieve a...
January 04, 2022 07:30 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Provide R&D Update, Including Expansion of Development-Stage RAS(ON) Inhibitor Pipeline, During Presentation at 40th Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies for RAS-addicted...
December 07, 2021 13:46 ET | Source: Aptive Environmental

Aptive Environmental Recognized On Inc.’s 2021 Best in Business List

PROVO, Utah, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Aptive Environmental, one of the fastest-growing pest control companies in North America, has been recognized on the Inc. 2021 Best in Business list as...
November 24, 2021 07:30 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Participate in 4th Annual Evercore ISI HealthCONx Conference

REDWOOD CITY, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
November 08, 2021 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Participate in Stifel 2021 Virtual Healthcare Conference

REDWOOD CITY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
November 03, 2021 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021

REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
November 03, 2021 12:15 ET | Source: Access

For the 12th Time, Access Recognized on the Inc. 5000, With Three-Year Revenue Growth of 43 Percent

WOBURN, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, today announced that it is being recognized for the...